1. TCT-511 Two-year Clinical Results with the Angiolite® Drug-Eluting Stent: The ANCHOR Study
- Author
-
Emilie Pelletier-Beaumont, Marc Amoros, José M. de la Torre Hernández, Josep Rodés-Cabau, Isabel Perez, Maria del Rosario Ortas-Nadal, Imanol Otaegui, Andrés Iñiguez, Stephen J. Nicholls, Antonio Serra, Rishi Puri, Bruno Diez Garcia, Victor Alfonso Jimenez Diaz, Manel Sabaté, Maria Dolores Molina, Marti Puigfel Pont, Luis Duocastella, Armando Pérez de Prado, Nieves Gonzalo, Felipe Fernández-Vázquez, Luis Nombela-Franco, and Carlos Cuellas-Ramón
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Percutaneous coronary intervention ,Stent ,equipment and supplies ,Surgery ,surgical procedures, operative ,Drug-eluting stent ,Conventional PCI ,Durable polymer ,Medicine ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business - Abstract
Pre-clinical results of a novel open-cell, thin strut, durable polymer, laser cut cobalt chromium sirolimus-eluting stent (Angiolite) were promising. We evaluated the 24-month clinical outcomes associated with percutaneous coronary intervention (PCI) with the Angiolite stent. This was a prospective
- Published
- 2018